RE:RE:RE:RE:RE:RE:RE:RE:It will be a pp. No jv for the Ph. 2b NMIBC indicationSkys your scenario is plausible and I had a similar situation with a Chinese biotech manufacturer . I thought it would be a multi bagger but had to settle for a 40% premium in a forced buyout . The only thing is that those type of takeouts have no competing bids . I'm assuming RW would prefer more than one bidder .
GLTA